CYTOSORBENTS CORPORATION: 10-Q filed 2011-08-15

Name: CYTOSORBENTS CORPORATION: 10-Q filed 2011-08-15
Creator: CYTOSORBENTS CORPORATION

What CYTOSORBENTS CORPORATION reported in its quarterly report filed 2011-08-15 (fiscal Q2 2011): 24 published measures, 69 facts as tagged in accession 0001144204-11-047506.

This filing

Form: 10-Q (quarterly report)
Filed: 2011-08-15
Fiscal period: fiscal Q2 2011
Accession: 0001144204-11-047506 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All CYTOSORBENTS CORPORATION filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2011-06-30	3,862,477	USD
At 2010-12-31	1,811,926	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2011-06-30	1,945,134	USD
At 2010-12-31	2,296,507	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2011-06-30	1,917,343	USD
At 2010-12-31	-484,581	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2011-06-30	3,416,525	USD
At 2010-12-31	1,055,669	USD
At 2010-06-30	595,524	USD
At 2009-12-31	1,595,628	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2011-04-01 to 2011-06-30	-1,341,182	USD	91
2011-01-01 to 2011-06-30	-2,555,766	USD	181
1997-01-22 to 2011-06-30	-81,221,037	USD	5273
2010-04-01 to 2010-06-30	-676,278	USD	91
2010-01-01 to 2010-06-30	-1,645,329	USD	181

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2011-01-01 to 2011-06-30	-1,620,559	USD	181
1997-01-22 to 2011-06-30	-60,369,441	USD	5273
2010-01-01 to 2010-06-30	-1,174,561	USD	181

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2011-01-01 to 2011-06-30	17,065	USD	181
1997-01-22 to 2011-06-30	2,383,353	USD	5273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2011-01-01 to 2011-06-30	4,009,813	USD	181
1997-01-22 to 2011-06-30	68,242,069	USD	5273
2010-01-01 to 2010-06-30	190,000	USD	181

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2011-01-01 to 2011-06-30	-28,398	USD	181
1997-01-22 to 2011-06-30	-4,456,103	USD	5273
2010-01-01 to 2010-06-30	-15,543	USD	181

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Value	Unit	Days
1997-01-22 to 2011-06-30	-547,318	USD	5273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2011-06-30	139,104	USD
At 2010-12-31	144,146	USD

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2011-06-30	3,452,138	USD
At 2010-12-31	1,400,205	USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2011-06-30	1,418,580	USD
At 2010-12-31	1,219,119	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2011-06-30	832,620	USD
At 2010-12-31	817,701	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2011-04-01 to 2011-06-30	1,114,159	USD	91
2011-01-01 to 2011-06-30	2,242,650	USD	181
1997-01-22 to 2011-06-30	75,639,783	USD	5273
2010-04-01 to 2010-06-30	674,377	USD	91
2010-01-01 to 2010-06-30	1,642,154	USD	181

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2011-04-01 to 2011-06-30	854,827	USD	91
2011-01-01 to 2011-06-30	1,613,984	USD	181
1997-01-22 to 2011-06-30	49,625,077	USD	5273
2010-04-01 to 2010-06-30	352,888	USD	91
2010-01-01 to 2010-06-30	1,034,103	USD	181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2011-06-30	165,869,400	shares
At 2010-12-31	122,838,411	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2011-06-30	89,914,220	USD
At 2010-12-31	83,375,544	USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

Period	Value	Unit	Days
At 2011-06-30	271,235	USD
At 2010-12-31	267,575	USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

Period	Value	Unit	Days
At 2011-06-30	35,613	USD
At 2010-12-31	344,536	USD

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

Period	Value	Unit	Days
2011-04-01 to 2011-06-30	-2,219,108	USD	91
2011-01-01 to 2011-06-30	-4,175,337	USD	181
1997-01-22 to 2011-06-30	-88,164,187	USD	5273
2010-04-01 to 2010-06-30	-1,089,965	USD	91
2010-01-01 to 2010-06-30	-2,840,380	USD	181

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2011-04-01 to 2011-06-30	191,802	USD	91
2011-01-01 to 2011-06-30	461,894	USD	181
1997-01-22 to 2011-06-30	24,288,178	USD	5273
2010-04-01 to 2010-06-30	194,043	USD	91
2010-01-01 to 2010-06-30	407,673	USD	181

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

Period	Value	Unit	Days
1997-01-22 to 2011-06-30	183,556	USD	5273

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2011-04-01 to 2011-06-30	-227,023	USD	91
2011-01-01 to 2011-06-30	-313,116	USD	181
1997-01-22 to 2011-06-30	-6,128,572	USD	5273
2010-04-01 to 2010-06-30	-1,901	USD	91
2010-01-01 to 2010-06-30	-3,175	USD	181

Inspect the source

Entity: CYTOSORBENTS CORPORATION / CIK 0001175151
Captured: 2026-09-20T07:44:44.168Z
SEC response SHA-256: 8bb195ec858f16302b2a8454a5ffe3eff6c1e6cd0312136a64a7a2f621b86836

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001175151.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))